Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Talbot

Showing results (531-540 of 576) with videos related to

Pageof 58
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2010
Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose studyDenis C Talbot, Malcolm Ranson, Joanna Davies, et al.
British Journal of Cancer|May 14, 1998
The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation systemJ C Fox, J England, P White, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1998
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family historyI M Frayling, N E Beck, M Ilyas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesisJ P Braybrooke, K J O'Byrne, D J Propper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase CD J Propper, A C McDonald, A Man, et al.
Plos One|September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for DiagnosisPamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
Peerj|May 6, 2021
ZebraShare: a new venue for rapid dissemination of zebrafish mutant dataApril DeLaurier, Douglas G Howe, Leyla Ruzicka, et al.
American Journal of Human Genetics|April 1, 1996
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6qH J Thomas, S C Whitelaw, S E Cottrell, et al.
Gastroenterology|February 1, 1997
Clinical and molecular features of the hereditary mixed polyposis syndromeS C Whitelaw, V A Murday, I P Tomlinson, et al.
Pageof 58

Showing results (531-540 of 576) with videos related to

Sort By:
Pageof 58
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2010
Tumor survivin is downregulated by the antisense oligonucleotide LY2181308: a proof-of-concept, first-in-human dose studyDenis C Talbot, Malcolm Ranson, Joanna Davies, et al.
British Journal of Cancer|May 14, 1998
The detection of K-ras mutations in colorectal cancer using the amplification-refractory mutation systemJ C Fox, J England, P White, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1998
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family historyI M Frayling, N E Beck, M Ilyas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
A phase II study of razoxane, an antiangiogenic topoisomerase II inhibitor, in renal cell cancer with assessment of potential surrogate markers of angiogenesisJ P Braybrooke, K J O'Byrne, D J Propper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2001
Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase CD J Propper, A C McDonald, A Man, et al.
Plos One|September 15, 2016
Targeted Next-Generation Sequencing of Plasma DNA from Cancer Patients: Factors Influencing Consistency with Tumour DNA and Prospective Investigation of Its Utility for DiagnosisPamela J Kaisaki, Anthony Cutts, Niko Popitsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanomaJeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
Peerj|May 6, 2021
ZebraShare: a new venue for rapid dissemination of zebrafish mutant dataApril DeLaurier, Douglas G Howe, Leyla Ruzicka, et al.
American Journal of Human Genetics|April 1, 1996
Genetic mapping of hereditary mixed polyposis syndrome to chromosome 6qH J Thomas, S C Whitelaw, S E Cottrell, et al.
Gastroenterology|February 1, 1997
Clinical and molecular features of the hereditary mixed polyposis syndromeS C Whitelaw, V A Murday, I P Tomlinson, et al.
Pageof 58